2-((4-BENZYL)-1-PIPERIDINYL)METH YL)BENZIMIDAZOLE-5-OL DERIVATIVES AS NR2B RECEPTOR ANTAGONISTS

Details for Australian Patent Application No. 2003291074 (hide)

Owner MERCK AND CO., INC.

Inventors Claremon, David A.; Liverton, Nigel J.; Maccauley, James A.

Agent Spruson & Ferguson

Pub. Number AU-A-2003291074

PCT Number PCT/US2003/0368

PCT Pub. Number WO2004/048364

Priority 60/428,410 22.11.02 US

Filing date 18 November 2003

Wipo publication date 18 June 2004

International Classifications

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

Event Publications

8 April 2004 Complete Application Filed

  Priority application(s): 60/428,410 22.11.02 US

22 July 2004 Application Open to Public Inspection

  Published as AU-A-2003291074

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003291075-APPARATUS AND METHOD FOR BENDING GLASS SHEETS

2003291073-A METHOD FOR CLONING OF A RARE, SPECIFICALLY MUTATED CELL